ePharmacies: Global Strategic Business Report

Report
193 Pages
April 2024
Region: Global
Global Industry Analysts, Inc
ID: 1882091

Global ePharmacies Market to Reach $277.8 Billion by 2030

The global market for ePharmacies estimated at US$85.3 Billion in the year 2022, is projected to reach a revised size of US$277.8 Billion by 2030, growing at a CAGR of 15.9% over the analysis period 2022-2030. Over-the-Counter Products, one of the segments analyzed in the report, is projected to record 15.3% CAGR and reach US$356.1 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Prescription Medicine segment is readjusted to a revised 16.9% CAGR for the next 8-year period.

The U.S. Market is Estimated at $25 Billion, While China is Forecast to Grow at 15.1% CAGR

The ePharmacies market in the U.S. is estimated at US$25 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$47.4 Billion by the year 2030 trailing a CAGR of 15.1% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 13.2% and 12.6% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 9.6% CAGR.

Select Competitors (Total 37 Featured) -

1mg Technologies Pvt. Ltd.
Canada Drugs
DocMorris NV
Dr Fox Pharmacy
eDrugstore.com
Express Scripts Holding Company
Giant Eagle, Inc.
InternationalDrugMart.com
MediSave
Netmeds Marketplace Limited
OptumRx, Inc.
PlanetRx
Rowlands Pharmacy
The Kroger Company
Walgreen Co.,
Wal-Mart Stores, Inc.
Zur Rose Group AG

What's New?

Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
Global competitiveness and key competitor percentage market shares
Market presence across multiple geographies - Strong/Active/Niche/Trivial
Online interactive peer-to-peer collaborative bespoke updates
Access to digital archives and Research Platform
Complimentary updates for one year

I. METHODOLOGYII. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Influencer Market Insights
World Market Trajectories
ePharmacy on the Roll Despite Stumbling Blocks
Recent Market Activity
Inherent Benefits of the Channel - A Key Driving Factor
Regulations - A Game Changer for the ePharmacy Market
Legal Status of Online Sale of Medications - Prescription and Non-Prescription in Select Markets
ePharmacies - Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

1mg Technologies Pvt. Ltd. (India)
Canada Drugs (Canada)
Dr Fox Pharmacy (UK)
eDrugstore.com (USA)
Express Scripts Holding Company (USA)
Giant Eagle, Inc. (USA)
InternationalDrugMart.com (Cyprus)
Lloyds Pharmacy Ltd. (UK)
MediSave (Canada)
Netmeds Marketplace Limited (India)
OptumRx, Inc. (USA)
PlanetRx (UK)
Rowlands Pharmacy (UK)
Sanicare-Apotheke (Germany)
T.mall.com (China)
The Kroger Company (USA)
Walgreen Co. (USA)
Wal-Mart Stores, Inc. (USA)
Yihaodian (China)
Zur Rose Group AG (Switzerland)
DocMorris NV (Netherlands)

3. MARKET TRENDS & DRIVERS

ePharmacies Bring Potential Value to Customers
ePharmacies Enable Better Care and Enhance Quality of Life
Prescription Drugs Fuel the Growth of Electronic Pharmacies
Increasing Healthcare Spending in Emerging Markets: Opportunities in Store
Ballooning Elderly Population: The Vital Growth Driver
Internet Globalizes Drug Sales through ePharmacies
Expanding Internet User Base: A Key Driving Force
Rising Smartphone Usage Supports Growing Adoption
Re-importation or Cross Border Drug Sales: An Area of Concern in the US
Cyber Crime in the Name of ePharmacies on the Rise
Online Pharmacies Growth Leads to Global Presence of Counterfeit Drugs
Perils of Counterfeit and Fake Drugs
Operation Pangea X - A Major Crackdown against Illegal Online Pharmacies

4. GLOBAL MARKET PERSPECTIVE

Table 1: World Current & Future Analysis for ePharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Table 2: World Historic Review for ePharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Table 3: World 15-Year Perspective for ePharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
Table 4: World Current & Future Analysis for Over-the-Counter Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Table 5: World Historic Review for Over-the-Counter Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Table 6: World 15-Year Perspective for Over-the-Counter Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
Table 7: World Current & Future Analysis for Prescription Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Table 8: World Historic Review for Prescription Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Table 9: World 15-Year Perspective for Prescription Medicine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES

ePharmacies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
Table 10: USA Current & Future Analysis for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Table 11: USA Historic Review for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Table 12: USA 15-Year Perspective for ePharmacies by Product Segment - Percentage Breakdown of Value Sales for Over-the-Counter Products and Prescription Medicine for the Years 2012, 2020 & 2027

CANADA

Table 13: Canada Current & Future Analysis for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Table 14: Canada Historic Review for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Table 15: Canada 15-Year Perspective for ePharmacies by Product Segment - Percentage Breakdown of Value Sales for Over-the-Counter Products and Prescription Medicine for the Years 2012, 2020 & 2027

JAPAN

ePharmacies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
Table 16: Japan Current & Future Analysis for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Table 17: Japan Historic Review for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Table 18: Japan 15-Year Perspective for ePharmacies by Product Segment - Percentage Breakdown of Value Sales for Over-the-Counter Products and Prescription Medicine for the Years 2012, 2020 & 2027

CHINA

ePharmacies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
Table 19: China Current & Future Analysis for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Table 20: China Historic Review for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Table 21: China 15-Year Perspective for ePharmacies by Product Segment - Percentage Breakdown of Value Sales for Over-the-Counter Products and Prescription Medicine for the Years 2012, 2020 & 2027

EUROPE

ePharmacies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
Table 22: Europe Current & Future Analysis for ePharmacies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Table 23: Europe Historic Review for ePharmacies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Table 24: Europe 15-Year Perspective for ePharmacies by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
Table 25: Europe Current & Future Analysis for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Table 26: Europe Historic Review for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Table 27: Europe 15-Year Perspective for ePharmacies by Product Segment - Percentage Breakdown of Value Sales for Over-the-Counter Products and Prescription Medicine for the Years 2012, 2020 & 2027

FRANCE

ePharmacies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
Table 28: France Current & Future Analysis for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Table 29: France Historic Review for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Table 30: France 15-Year Perspective for ePharmacies by Product Segment - Percentage Breakdown of Value Sales for Over-the-Counter Products and Prescription Medicine for the Years 2012, 2020 & 2027

GERMANY

ePharmacies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
Table 31: Germany Current & Future Analysis for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Table 32: Germany Historic Review for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Table 33: Germany 15-Year Perspective for ePharmacies by Product Segment - Percentage Breakdown of Value Sales for Over-the-Counter Products and Prescription Medicine for the Years 2012, 2020 & 2027

ITALY

Table 34: Italy Current & Future Analysis for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Table 35: Italy Historic Review for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Table 36: Italy 15-Year Perspective for ePharmacies by Product Segment - Percentage Breakdown of Value Sales for Over-the-Counter Products and Prescription Medicine for the Years 2012, 2020 & 2027

UNITED KINGDOM

ePharmacies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
Table 37: UK Current & Future Analysis for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Table 38: UK Historic Review for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Table 39: UK 15-Year Perspective for ePharmacies by Product Segment - Percentage Breakdown of Value Sales for Over-the-Counter Products and Prescription Medicine for the Years 2012, 2020 & 2027

REST OF EUROPE

Table 40: Rest of Europe Current & Future Analysis for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Table 41: Rest of Europe Historic Review for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Table 42: Rest of Europe 15-Year Perspective for ePharmacies by Product Segment - Percentage Breakdown of Value Sales for Over-the-Counter Products and Prescription Medicine for the Years 2012, 2020 & 2027

ASIA-PACIFIC

ePharmacies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
Table 43: Asia-Pacific Current & Future Analysis for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Table 44: Asia-Pacific Historic Review for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Table 45: Asia-Pacific 15-Year Perspective for ePharmacies by Product Segment - Percentage Breakdown of Value Sales for Over-the-Counter Products and Prescription Medicine for the Years 2012, 2020 & 2027

REST OF WORLD

Table 46: Rest of World Current & Future Analysis for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Table 47: Rest of World Historic Review for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Table 48: Rest of World 15-Year Perspective for ePharmacies by Product Segment - Percentage Breakdown of Value Sales for Over-the-Counter Products and Prescription Medicine for the Years 2012, 2020 & 2027

IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

1mg Technologies Pvt. Ltd.
Canada Drugs
DocMorris NV
Dr Fox Pharmacy
eDrugstore.com
Express Scripts Holding Company
Giant Eagle, Inc.
InternationalDrugMart.com
MediSave
Netmeds Marketplace Limited
OptumRx, Inc.
PlanetRx
Rowlands Pharmacy
The Kroger Company
Walgreen Co.,
Wal-Mart Stores, Inc.
Zur Rose Group AG

Table Information

Report Attribute	Details
No. of Pages	193
Published	April 2024
Forecast Period	2020 - 2027
Estimated Market Value ( USD ) in 2020	$ 57.4 Billion
Forecasted Market Value ( USD ) by 2027	$ 266.5 Billion
Compound Annual Growth Rate	24.5%
Regions Covered	Global

PURCHASE OPTIONS

Single User License PDF

1 - 10 User License PDF

Enterprise License PDF

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€5303EUR$5,450USD£4,543GBP
1 - 10 USER LICENSE PDF	The product is a PDF.	This is a 1-10 user license, allowing up to ten users have access to the product.	€10075EUR$10,355USD£8,631GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€15908EUR$16,350USD£13,628GBP

Global ePharmacies Market to Reach $277.8 Billion by 2030

The U.S. Market is Estimated at $25 Billion, While China is Forecast to Grow at 15.1% CAGR

Select Competitors (Total 37 Featured) -

What's New?

Table of Contents

Companies Mentioned (Partial List)

Table Information

Related Topics

Related Reports

ePharmacy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Global ePharmacy Market by Product (Cold & Flu, Dental, Skin Care), Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs), Type, Business model - Forecast 2024-2030

Global E-Pharmacy Market Overview, 2023-28

ePharmacy Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030

Global ePharmacy Market 2024-2028